Current sickle cell disease management practices in Nigeria

International Health

Volumn 6, Issue 1, 2014, Pages 23-28

  Galadanci, N ^a   Wudil, B J ^b   Balogun, T M ^c   Ogunrinde, G O ^d   Akinsulie, A ^e   Hasan hanga, F ^a   Mohammed, A S ^d   Kehinde, M O ^e   Olaniyi, J A ^f   Diaku akinwumi, I N ^c   Brown, B J ^f   Adeleke, S ^g   Nnodu, O E ^g   Emodi, I ^h   Ahmed, S ^a   Osegbue, A O ⁱ   Akinola, N ^j   Opara, H I O ^k   Adegoke, S A ^j   Aneke, J ^k   Adekile, A D ^l   more..

^a AMINU KANO TEACHING HOSPITAL   (Nigeria)

^b Murtala Mohammed Specialist Hospital   (Nigeria)

^c LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^d AHMADU BELLO UNIVERSITY   (Nigeria)

^e LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^f UNIVERSITY OF IBADAN   (Nigeria)

^g UNIVERSITY OF ABUJA   (Nigeria)

^h UNIVERSITY OF NIGERIA   (Nigeria)

ⁱ Sickle Cell Foundation of Nigeria   (Nigeria)

^j OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^k FEDERAL MEDICAL CENTER   (Nigeria)

^l KUWAIT UNIVERSITY   (Kuwait)

more..

Author keywords

Future projections; Management; Nigeria; Sickle cell disease

Indexed keywords

FOLIC ACID; HEMOGLOBIN; HERBACEOUS AGENT; HYDROXYUREA; MALARIA VACCINE; OMEGA 3 FATTY ACID; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CELL COUNTER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ELECTROPHORESIS; HEALTH CARE SURVEY; HEALTH CARE UTILIZATION; HEMOGLOBIN ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALARIA; MALARIA CONTROL; NIGERIA; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SICKLE CELL ANEMIA; VACCINATION;

FUTURE PROJECTIONS; MANAGEMENT; NIGERIA; SICKLE CELL DISEASE;

ANEMIA, SICKLE CELL; DELIVERY OF HEALTH CARE; HEALTH CARE SURVEYS; HEALTH FACILITIES; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; HYDROXYUREA; INFANT, NEWBORN; NEONATAL SCREENING; NIGERIA; PRIMARY HEALTH CARE; QUESTIONNAIRES;

EID: 84896811197     PISSN: 18763413     EISSN: 18763405     Source Type: Journal    
DOI: 10.1093/inthealth/iht022     Document Type: Article

References (33)

1. Modell B, Darlison M, Birgens H et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest 2007;67: 39-69.
2. Fleming AF, Storey J, Molineaux L et al. Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann Trop Med Parasitol 1979;73:161-72.
3. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med 2008;44:1506-28.
4. Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program 2008: 177-85.
5. Noubouossie DF, Lê PQ, Corazza F et al. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children. Am J Hematol 2012;87:145-9.
6. Gill FM, Sleeper LA,Weiner SJ et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995;86:776-83.
7. Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 1971;50:97-112.
8. Khatib R, Rabah R, Sarnaik SA. The spleen in the sickling disorders: an update. Pediatr Radiol 2009;39:17-22.
9. Castro O, Brambilla D, Thorington B et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9.
10. Ohene-Frempong K, Weiner SJ, Sleeper LA et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91:288-94.
11. Oliveira CC, Ciasca SM, Moura-Ribeiro MV. Stroke in patients with sickle cell disease: clinical and neurological aspects. Arq Neuropsiquiatr 2008;66:30-3.
12. Powars DR. Sickle cell anemia and major organ failure. Hemoglobin 1990;14:573-98.
13. Scheinman JI. Sickle cell disease and the kidney. Semin Nephrol 2003;23:66-76.
14. Ladizinski B, Bazakas A, Mistry N et al. Sickle cell disease and leg ulcers. Adv Skin Wound Care 2012;25:420-8.
15. Hernigou P, Galacteros F, Bachir D et al. Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients. J Bone Joint Surg Am 1991; 73:81-92.
16. Williams TN, Obaro SK. Sickle cell disease and malaria morbidity: a tale with two tails. Trends Parasitol 2011;27:315-20.
17. McAuley CF, Webb C, Makani J et al. High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood 2010;116:1663-8.
18. Quinn CT, Rogers ZR, McCavit TL et al. Improved survival of children and adolescents with sickle cell disease. Blood 2010;115:3447-52.
19. Wang CJ, Kavanagh PL, Little AA et al. Quality-of-care indicators for children with sickle cell disease. Pediatrics 2011;128:484-93.
20. Cober MP, Phelps SJ. Penicillin prophylaxis in children with sickle cell disease. J Pediatr Pharmacol Ther 2010;15:152-9.
21. Hardie R, King L, Fraser R et al. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening. Ann Trop Paediatr 2009;29:197-202.
22. Ellison AM, Ota KV, McGowan KL et al. Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population. Pediatr Infect Dis J 2012;31:534-6.
23. Lee MT, Piomelli S, Granger S et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood 2006; 108:847-52.
24. Malouf AJ Jr, Hamrick-Turner JE, Doherty MC et al. Implementation of the STOP protocol for Stroke Prevention in Sickle Cell Anemia by using duplex power Doppler imaging. Radiology 2001;219: 359-65.
25. Charache S. Hydroxyurea as treatment for sickle cell anemia. Hematol Oncol Clin North Am 1991;5:571-83.
26. Heeney MM,Ware RE. Hydroxyurea for children with sickle cell disease. Hematol Oncol Clin North Am 2010;24:199-214.
27. World Bank. Nigeria. http://www.worldbank.org/en/country/nigeria [accessed 11 March 2013].
28. WHO. The Nigerian health system. http://www.who.int/pmnch/countries/nigeria-plan-chapter-3.pdf [accessed 11 March 2013].
29. Akinyanju O, Johnson AO. Acute illness in Nigerian children with sickle cell anaemia. Ann Trop Paediatr 1987;7:181-6.
30. Akuse RM. Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission. J Trop Pediatr 1996; 42:318-23.
31. Kizito ME, Mworozi E, Ndugwa C et al. Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? Arch Dis Child 2007;92:21-3.
32. de Montalembert M, Brousse V, Zahar JR. Pneumococcal prophylaxis for children with sickle cell disease in Africa. Arch Dis Child 2008; 93:715-6.
33. Obaro S. Pneumococcal infections and sickle cell disease in Africa: does absence of evidence imply evidence of absence? Arch Dis Child 2009;94:713-6.